Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serotonin6 receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson's rats
Kuncheng Liu, Junyi Li, Huihui Tan, et al.
Neuropharmacology (2015) Vol. 95, pp. 290-298
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Depression in neurodegenerative diseases: Common mechanisms and current treatment options
Ciarán Galts, Luis E.B. Bettio, David C. Jewett, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 102, pp. 56-84
Closed Access | Times Cited: 212
The hidden side of Parkinson’s disease: Studying pain, anxiety and depression in animal models
Fanny Faivre, Anil Joshi, Erwan Bézard, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 96, pp. 335-352
Open Access | Times Cited: 62
Age-Related Change in 5-HT6 Receptor Availability in Healthy Male Volunteers Measured with 11C-GSK215083 PET
Rajiv Radhakrishnan, Nabeel Nabulsi, Edward Gaiser, et al.
Journal of Nuclear Medicine (2018) Vol. 59, Iss. 9, pp. 1445-1450
Open Access | Times Cited: 55
The pathobiological basis of depression in Parkinson disease: challenges and outlooks
K. A. Jellinger
Journal of Neural Transmission (2022) Vol. 129, Iss. 12, pp. 1397-1418
Open Access | Times Cited: 27
Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus
S. Poggini, Maria Teresa Golia, Silvia Alboni, et al.
Neural Plasticity (2019) Vol. 2019, pp. 1-12
Open Access | Times Cited: 36
Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
Kathy Dujardin, Véronique Sgambato‐Faure
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 36
Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models
Shawn Hayley, F. Vahid-Ansari, Sun Hongyu, et al.
Neurobiology of Disease (2023) Vol. 181, pp. 106115-106115
Open Access | Times Cited: 11
Neurobiological findings underlying depressive behavior in Parkinson’s disease: A review
Ingrid Prata Mendonça, Eduardo Duarte-Silva, Adriano José Maia Chaves-Filho, et al.
International Immunopharmacology (2020) Vol. 83, pp. 106434-106434
Closed Access | Times Cited: 32
Neuropsychiatric and Cognitive Deficits in Parkinson’s Disease and Their Modeling in Rodents
Mélina Decourt, Haritz Jiménez‐Urbieta, Marianne Benoit‐Marand, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 684-684
Open Access | Times Cited: 25
Investigating the Shared Genetic Etiology Between Parkinson’s Disease and Depression
Paula Reyes‐Pérez, Luis M. García‐Marín, Asma M. Aman, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 3, pp. 483-493
Open Access | Times Cited: 3
Activation and blockade of serotonin6 receptors in the dorsal hippocampus enhance T maze and hole-board performance in a unilateral 6-hydroxydopamine rat model of Parkinson's disease
Kun Cheng Liu, Jun Yi Li, Wen Xie, et al.
Brain Research (2016) Vol. 1650, pp. 184-195
Closed Access | Times Cited: 25
Activation and blockade of serotonin7 receptors in the prelimbic cortex regulate depressive-like behaviors in a 6-hydroxydopamine-induced Parkinson’s disease rat model
Q.J. Zhang, Chengxue Du, Huihui Tan, et al.
Neuroscience (2015) Vol. 311, pp. 45-55
Closed Access | Times Cited: 22
Activation and blockade of prelimbic 5-HT6 receptors produce different effects on depressive-like behaviors in unilateral 6-hydroxydopamine-induced Parkinson's rats
Yuming Zhang, Li Zhang, Yong Wang, et al.
Neuropharmacology (2016) Vol. 110, pp. 25-36
Closed Access | Times Cited: 21
5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer’s disease
Nasrin Hashemi-Firouzi, ‬Siamak Shahidi, Sara Soleimani Asl, et al.
Metabolic Brain Disease (2018) Vol. 33, Iss. 4, pp. 1243-1253
Closed Access | Times Cited: 20
Commentary: Evaluation of Models of Parkinson's Disease
Pollyana Caldeira Leal, Lívia C.R.F. Lins, Auderlan M. Gois, et al.
Frontiers in Neuroscience (2016) Vol. 10
Open Access | Times Cited: 18
Involvement of the Dorsal Hippocampus 5-HT<sub>1A</sub> Receptors in the Regulation of Depressive-Like Behaviors in Hemiparkinsonian Rats
Yi-Fan Jiang, Jian Liu, Jie Yang, et al.
Neuropsychobiology (2020) Vol. 79, Iss. 3, pp. 198-207
Closed Access | Times Cited: 17
Ablation of the tail of the ventral tegmental area compensates symptoms in an experimental model of Parkinson's disease
Fanny Faivre, María José Sánchez-Catalán, Sandra Doveró, et al.
Neurobiology of Disease (2020) Vol. 139, pp. 104818-104818
Open Access | Times Cited: 17
A tricyclic antidepressant, amoxapine, reduces amyloid-β generation through multiple serotonin receptor 6-mediated targets
Xiaohang Li, Qinying Wang, T. Hu, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 18
Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease
Veronica Antipova, Carsten Holzmann, Alexander Hawlitschka, et al.
Toxins (2021) Vol. 13, Iss. 7, pp. 505-505
Open Access | Times Cited: 13
Serotonergic dysfunction in a model of parkinsonism induced by reserpine
Pollyana Caldeira Leal, José M.M. Bispo, Rovena Clara Galvão Januário Engelberth, et al.
Journal of Chemical Neuroanatomy (2018) Vol. 96, pp. 73-78
Closed Access | Times Cited: 16
Cognitive and anxiety-like impairments accompanied by serotonergic ultrastructural and immunohistochemical alterations in early stages of parkinsonism
Pollyana Caldeira Leal, José M.M. Bispo, Lucas Correia Lins, et al.
Brain Research Bulletin (2019) Vol. 146, pp. 213-223
Open Access | Times Cited: 15
Intracerebroventricular injection of deltamethrin increases locomotion activity and causes spatial working memory and dopaminergic pathway impairment in rats
Marina F. Souza, Katty A.A.L. Medeiros, Lívia C.R.F. Lins, et al.
Brain Research Bulletin (2019) Vol. 154, pp. 1-8
Open Access | Times Cited: 15
Activation and blockade of dorsal hippocampal Serotonin6 receptors regulate anxiety-like behaviors in a unilateral 6-hydroxydopamine rat model of Parkinson’s disease
Kun Cheng Liu, Yuan Guo, Jin Zhang, et al.
Neurological Research (2019) Vol. 41, Iss. 9, pp. 791-801
Closed Access | Times Cited: 14
The blockade of the serotoninergic receptors 5-HT5A, 5-HT6 and 5-HT7 in the basolateral amygdala, but not in the hippocampus facilitate the extinction of fear memory
Eduardo Silva de Assis Brasil, Cristiane Regina Guerino Furini, Fernanda da Silva Rodrigues, et al.
Behavioural Brain Research (2019) Vol. 372, pp. 112055-112055
Closed Access | Times Cited: 14
Heart failure impairs mood and memory in male rats and down-regulates the expression of numerous genes important for synaptic plasticity in related brain regions
Marise B. Parent, Hildebrando Candido Ferreira‐Neto, Ana Rafaela Kruemmel, et al.
Behavioural Brain Research (2021) Vol. 414, pp. 113452-113452
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top